Internal Medicine, Infectious Disease · Apple Valley, CA
NPI
1477968006
Since 2014
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
18300 US Highway 18
Apple Valley, CA, 92307
Phone (999) 999-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
549 services
Medicare patients, 2024
111
Average age 69
Drug cost, 2024
$628K
351 prescriptions
Company payments, 2025
$261
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashwini Mallad was code 99233 (hospital e&m - subsequent), 280 times for 67 patients. In total Ashwini Mallad billed 549 services in 14 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 280 | 67 | $94.13 | $26K |
| 99223 Hospital E&M - Initial | Facility | 79 | 74 | $137.78 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 26 | $62.84 | $3,456 |
| 99214 Office E&M - Established | Office | 46 | 18 | $84.81 | $3,901 |
By year: 2022 $63K for 558 services; 2023 $40K for 406 services; 2024 $54K for 549 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashwini Mallad prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 77 prescriptions and refills. In total Ashwini Mallad wrote 351 Medicare prescriptions that cost $628K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 77 | 81 | 11 | $313K |
| Rifampin Generic | 36 | 40 | 13 | $1,029 |
| Isoniazid Generic | 23 | 23 | Under 11 | $95.82 |
| Vancomycin Hcl Generic | 21 | 21 | Under 11 | $3,076 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 21 | 25 | Under 11 | $87K |
| Priftin Rifapentine | 16 | 16 | Under 11 | $1,590 |
| Dovato Dolutegravir Sodium/Lamivudine | 16 | 16 | Under 11 | $50K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 12 | Under 11 | $45.3 |
| Fluconazole Generic | 11 | 11 | Under 11 | $406 |
Brand drugs: 156 claims; generic drugs: 195 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashwini Mallad $261 ($261 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $77.18.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.